Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection

N Hensel, Z Gu, Sagar, D Wieland, K Jechow… - Nature …, 2021 - nature.com
In chronic hepatitis C virus (HCV) infection, exhausted HCV-specific CD8+ T cells comprise
memory-like and terminally exhausted subsets. However, little is known about the molecular …

Immune checkpoints in the tumor microenvironment

SM Toor, VS Nair, J Decock, E Elkord - Seminars in cancer biology, 2020 - Elsevier
Interactions between immune checkpoints (ICs) and their ligands negatively regulate T cell
activation pathways involved in physiological immune responses against specific antigens …

TOX promotes the exhaustion of antitumor CD8+ T cells by preventing PD1 degradation in hepatocellular carcinoma

X Wang, Q He, H Shen, A Xia, W Tian, W Yu, B Sun - Journal of hepatology, 2019 - Elsevier
Background & Aims The thymocyte selection-associated high mobility group box protein
(TOX) plays a vital role in T cell development and differentiation, however, its role in T cell …

[HTML][HTML] Targeting immune cells for cancer therapy

SY Gun, SWL Lee, JL Sieow, SC Wong - Redox biology, 2019 - Elsevier
Recent years have seen a renaissance in the research linking inflammation and cancer with
immune cells playing a central role in smouldering inflammation in the tumor …

Liver-mediated adaptive immune tolerance

M Zheng, Z Tian - Frontiers in immunology, 2019 - frontiersin.org
The liver is an immunologically tolerant organ that is uniquely equipped to limit
hypersensitivity to food-derived antigens and bacterial products through the portal vein and …

[HTML][HTML] Intratumoral CD103+ CD8+ T cells predict response to PD-L1 blockade

R Banchereau, AS Chitre, A Scherl, TD Wu… - … for ImmunoTherapy of …, 2021 - ncbi.nlm.nih.gov
Background CD8+ tissue-resident memory T (T RM) cells, marked by CD103 (ITGAE)
expression, are thought to actively suppress cancer progression, leading to the hypothesis …

Immunomodulatory potential of natural products from herbal medicines as immune checkpoints inhibitors: Helping to fight against cancer via multiple targets

Z Zhong, CT Vong, F Chen, H Tan… - Medicinal Research …, 2022 - Wiley Online Library
Immunotherapy sheds new light to cancer treatment and is satisfied by cancer patients.
However, immunotoxicity, single‐source antibodies, and single‐targeting stratege are …

VEGF-A drives TOX-dependent T cell exhaustion in anti–PD-1–resistant microsatellite stable colorectal cancers

CG Kim, M Jang, Y Kim, G Leem, KH Kim, H Lee… - Science …, 2019 - science.org
Although immune checkpoint blockade therapies have demonstrated clinical efficacy in
cancer treatment, harnessing this strategy is largely encumbered by resistance in multiple …

PD-1/PD-L1 in cancer: pathophysiological, diagnostic and therapeutic aspects

E Munari, FR Mariotti, L Quatrini, P Bertoglio… - International journal of …, 2021 - mdpi.com
Immune evasion is a key strategy adopted by tumor cells to escape the immune system
while promoting their survival and metastatic spreading. Indeed, several mechanisms have …

Immune system and hepatocellular carcinoma (HCC): new insights into HCC progression

M Kotsari, V Dimopoulou, J Koskinas… - International Journal of …, 2023 - mdpi.com
According to the WHO's recently released worldwide cancer data for 2020, liver cancer
ranks sixth in morbidity and third in mortality among all malignancies. Hepatocellular …